inside the rapidly evolving area of oncology research, precise and successful mutation screening is critical for developing focused therapies. The KRAS Services Platform plays a pivotal job Within this landscape by offering complete methods for KRAS mutation profiling and analysis. KRAS mutations, present in close to ninety five% of RAS-similar onc